Related Experiment Video
Updated: Mar 22, 2026

03:53
An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
611
Lung parenchima changes in neurofibromatosis type 1.
Vojnosanitetski Pregled
|April 14, 2016
Summary
Neurofibromatosis type 1 (NF1), a common genetic disorder, can manifest with rare thoracic abnormalities. This case report highlights NF1 associated with lung parenchymal changes discovered during intensive care.
Area of Science:
- Pulmonology
- Genetics
- Oncology
Background:
- Neurofibromatosis type 1 (NF1), or von Recklinghausen disease, is a frequent single-gene disorder linked to chromosome 17q.
- NF1 commonly presents with cutaneous, musculoskeletal, and neurological issues, often including tumors of the peripheral nervous system.
- Thoracic manifestations of NF1 are infrequently documented in medical literature.
Observation:
- A 65-year-old female with NF1 presented with severe shortness of breath and cyanosis.
- Skin changes consistent with NF1 were noted and confirmed by medical history.
- Initial treatment involved noninvasive mechanical ventilation, leading to patient improvement.
Findings:
- Diagnostic imaging, including X-rays and CT scans, revealed parenchymal abnormalities in the thorax.
- This case report details an association between NF1 and previously undocumented lung parenchymal abnormalities.
- The findings were established during diagnostic procedures in the Intensive Care Unit at the Clinic of Pulmonology.
Implications:
- This case underscores the importance of considering thoracic manifestations in patients diagnosed with NF1.
- Further investigation into the relationship between NF1 and lung parenchymal abnormalities is warranted.
- Enhanced diagnostic protocols may be necessary for early detection of pulmonary complications in NF1 patients.
More Related Videos
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
1.2K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.8K